Cargando…

EGFP标记的Lewis肺癌细胞构建裸鼠恶性胸腔积液模型

BACKGROUND AND OBJECTIVE: Malignant pleural effusion (MPE) is a poor prognosis factor in patients with advanced lung cancer. The aim of this study is to establish a mouse model of MPE using Lewis lung carcinoma (LLC) cell lines expressing enhanced green fluorescent protein (EGFP). METHODS: The mouse...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000302/
https://www.ncbi.nlm.nih.gov/pubmed/22681917
http://dx.doi.org/10.3779/j.issn.1009-3419.2012.06.01
_version_ 1783331675132919808
collection PubMed
description BACKGROUND AND OBJECTIVE: Malignant pleural effusion (MPE) is a poor prognosis factor in patients with advanced lung cancer. The aim of this study is to establish a mouse model of MPE using Lewis lung carcinoma (LLC) cell lines expressing enhanced green fluorescent protein (EGFP). METHODS: The mouse model was created by injecting LLC-EGFP cells directly into the pleural cavity of mice that were sacrificed periodically. The dynamic growth and metastasis of tumor cells were screened using in vivo fluorescence imaging. The remaining mice were subjected to transverse computed tomography (CT) imaging periodically to analyze the formation rate of pleural effusion. The survival rate and tumor metastasis were also observed. Pleural fluid was gently aspirated using a 1 mL syringe and its volume was measured. When two or more mice bore pleural effusion at the same time, we calculated the average volume. The correlation of pleural effusion with the integrated optical density (IOD) were analyzed. RESULTS: Four days after the inoculation of LLC-EGFP cells, green fluorescence was observed by opening the chest wall. The tumor formation rate was 100%, and the IOD gradually increased after inoculation. The metastasis sites were mediastinal, and the hilar lymph nodes were contralateral pleural as well as pericardial. The metastasis rates were 87%, 73% and 20%, respectively. The CT scan revealed that the formation rates of pleural effusion on days 7, 14 and 21 were 13%, 46% and 53%, respectively. The average volume of pleural effusion increased obviously on day 10 and peaked on day 16 with a value of 0.5 mL. The mean survival time of nude mice was 28.8 days. The volume of pleural effusion and IOD were significantly correlated (r=0.91, P < 0.000, 1). CONCLUSION: A mouse model of lung cancer malignant pleural effusion was successfully established by injecting LLC lines expressing EGFP into the pleural cavity under a microscope. The model can enable dynamic observations of the biological behavior of tumor cells in the pleural cavity. It might be helpful for basic research on advanced lung cancer as well as anti-tumor drug development.
format Online
Article
Text
id pubmed-6000302
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60003022018-07-06 EGFP标记的Lewis肺癌细胞构建裸鼠恶性胸腔积液模型 Zhongguo Fei Ai Za Zhi 基础研究 BACKGROUND AND OBJECTIVE: Malignant pleural effusion (MPE) is a poor prognosis factor in patients with advanced lung cancer. The aim of this study is to establish a mouse model of MPE using Lewis lung carcinoma (LLC) cell lines expressing enhanced green fluorescent protein (EGFP). METHODS: The mouse model was created by injecting LLC-EGFP cells directly into the pleural cavity of mice that were sacrificed periodically. The dynamic growth and metastasis of tumor cells were screened using in vivo fluorescence imaging. The remaining mice were subjected to transverse computed tomography (CT) imaging periodically to analyze the formation rate of pleural effusion. The survival rate and tumor metastasis were also observed. Pleural fluid was gently aspirated using a 1 mL syringe and its volume was measured. When two or more mice bore pleural effusion at the same time, we calculated the average volume. The correlation of pleural effusion with the integrated optical density (IOD) were analyzed. RESULTS: Four days after the inoculation of LLC-EGFP cells, green fluorescence was observed by opening the chest wall. The tumor formation rate was 100%, and the IOD gradually increased after inoculation. The metastasis sites were mediastinal, and the hilar lymph nodes were contralateral pleural as well as pericardial. The metastasis rates were 87%, 73% and 20%, respectively. The CT scan revealed that the formation rates of pleural effusion on days 7, 14 and 21 were 13%, 46% and 53%, respectively. The average volume of pleural effusion increased obviously on day 10 and peaked on day 16 with a value of 0.5 mL. The mean survival time of nude mice was 28.8 days. The volume of pleural effusion and IOD were significantly correlated (r=0.91, P < 0.000, 1). CONCLUSION: A mouse model of lung cancer malignant pleural effusion was successfully established by injecting LLC lines expressing EGFP into the pleural cavity under a microscope. The model can enable dynamic observations of the biological behavior of tumor cells in the pleural cavity. It might be helpful for basic research on advanced lung cancer as well as anti-tumor drug development. 中国肺癌杂志编辑部 2012-06-20 /pmc/articles/PMC6000302/ /pubmed/22681917 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.06.01 Text en 版权所有©《中国肺癌杂志》编辑部2012 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 基础研究
EGFP标记的Lewis肺癌细胞构建裸鼠恶性胸腔积液模型
title EGFP标记的Lewis肺癌细胞构建裸鼠恶性胸腔积液模型
title_full EGFP标记的Lewis肺癌细胞构建裸鼠恶性胸腔积液模型
title_fullStr EGFP标记的Lewis肺癌细胞构建裸鼠恶性胸腔积液模型
title_full_unstemmed EGFP标记的Lewis肺癌细胞构建裸鼠恶性胸腔积液模型
title_short EGFP标记的Lewis肺癌细胞构建裸鼠恶性胸腔积液模型
title_sort egfp标记的lewis肺癌细胞构建裸鼠恶性胸腔积液模型
topic 基础研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000302/
https://www.ncbi.nlm.nih.gov/pubmed/22681917
http://dx.doi.org/10.3779/j.issn.1009-3419.2012.06.01
work_keys_str_mv AT egfpbiāojìdelewisfèiáixìbāogòujiànluǒshǔèxìngxiōngqiāngjīyèmóxíng
AT egfpbiāojìdelewisfèiáixìbāogòujiànluǒshǔèxìngxiōngqiāngjīyèmóxíng
AT egfpbiāojìdelewisfèiáixìbāogòujiànluǒshǔèxìngxiōngqiāngjīyèmóxíng
AT egfpbiāojìdelewisfèiáixìbāogòujiànluǒshǔèxìngxiōngqiāngjīyèmóxíng
AT egfpbiāojìdelewisfèiáixìbāogòujiànluǒshǔèxìngxiōngqiāngjīyèmóxíng